Polar Capital Holdings’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-250,000
| Closed | -$4.71M | – | 280 |
|
|
2023
Q1 | $4.71M | Sell |
250,000
-250,000
| -50% | -$4.71M | 0.03% | 236 |
|
|
2022
Q4 | $7.96M | Hold |
500,000
| – | – | 0.06% | 210 |
|
|
2022
Q3 | $8.18K | Buy |
+500,000
| New | +$8.18K | 0.05% | 207 |
|
|
2021
Q2 | – | Sell |
-60,879
| Closed | -$1.57M | – | 348 |
|
|
2021
Q1 | $1.57M | Sell |
60,879
-101,837
| -63% | -$2.63M | 0.01% | 275 |
|
|
2020
Q4 | $8.7M | Buy |
+162,716
| New | +$8.7M | 0.05% | 218 |
|